��ժҪ��Ϣ

[an error occurred while processing this directive]

��Ƥ��Բ�ѧ��־ 2005, 31(1) 47-49 DOI: ISSN: 2096-5540 CN: 32-1880/R

��Ŀ¼ | ��Ŀ¼ | �� | �߼�� [��ӡ��ҳ] [�ر�]

��

	��չ��

	��Ϣ
	Supporting info
	PDFȫ��
	[HTMLȫ��]
	�ο��
	��뷴��
	�ѱ��Ƽ��
	��ҵ��
	��ù��
	��ñ��
	Email Alert
	��·��
	��Ϣ
	��Ĺؼ��
	��
	�׸л��λ��
	��ѡ��
	��
	��
	��ѧ��
	��ɭ
	PubMed
	Article by
	Article by
	Article by

��׸л��򼰺�ѡ��о��״

��, ��ѧ��, ��ɭ

��ҽ�ƴ�ѧƤ��о��ߵ�һ��ҽԺƤ�� Ϸ� 230032

ժҪ��

��Ĳ��в��ȷ,Ŀǰ��Ϊ�䷢��Ϊ�ڶ��ۼ�ЧӦ�Ļ��,ͬʱ�л��á�ͨ��ȫ��ɨ�輰��ѡ��о��ȷ��Ŵ��س��õ��Ҫ��,��о��ʾ��ͬ��ص��׸л��λ�㼰��ѡ��򲢲��ȫһ��,��Ľ��ȱ��ظ��ԡ�

�ؼ���� ׸л��λ�� ѡ��

Abstract:

Keywords:

�ո�� 2004-03-12 �޻�� ��淢��

DOI:

��Ŀ:

ͨѶ��:

��߼��:

�ο��ף�

[1] Arcos-Burgos M, Parodi E, Salgar M, et al. Vitiligo:complex segregation and linkage disequilibrium analyses with respect to microsatellite loci spanning the HLA. Hum Genet, 2002, 110:334-342.
[2] Zhang X J, Liu JB, Gui JP,et al. Characteristics of genetic epidemiology and genetic models for vitiligo. J Am Acad Dermatol, 2004, 51:383-390.
[3] Nath SK, Kelly JA, Namjou B, et al. Evidence for a susceptibility gene, SLEV1, on chromosome 17p13 in families with vitiligo-related systemic lupus erythematosus. Am J Hum Genet, 2001,69:1401.
[4] Alkhateeb A, Stetler GL, Old W, et al. Mapping of an autoimmunity susceptibility locus (AIS1) to chromosome lp31.3-p32.2. Hum Mol Genet, 2002, 11:661-667.
[5] Fain PR, Gowan K, LaBerge GS, et al. A genomewide screen for generalized vitiligo:confirmation of AIS1 on chromosome 1p31 and evidence for additional susceptibility loci. Am J Hum Genet, 2003,72:1560-1564.
[6] Nyholt DR. All LODs are not created equal. Am J Hum Genet, 2000, 67:282-288.
[7] Spritz RA, Gowan K, Bennett DC, et al. Novel vitiligo susceptibility loci on chromosomes 7 (AIS2) and 8 (AIS3), confirmation of SLEV1 on chromosome 17, and their roles in an autoimmune diathesis. Am J Hum Genet, 2004, 74:188-191.
[8] Kemp EH, Ajjan RA, Waterman EA, et al. Analysis of a microsatellite polymorphism of the cytotoxic T-lymphocyte antigen-4 gene in patients with vitiligo. Br J Dermatol, 1999, 140:73-78.
[9] al-Fouzan A, al-Arbash M, Fouad F, et al. Study of HLA class ��/IL and T lymphocyte subsets in Kuwaiti vitiligo patients. Eur J Immunogenet, 1995, 22:209-213.
[10] Orecchia G, Perfetti L, Malagoli P,et al. Vitiligo is associated with a significant increase in HLA-A30, Cw6 and DQw3 and a decrease inC4AQ0 in northern Italian patients. Dermatology, 1992, 185:123.
[11] Zamani M, Spaepen M, Sghar SS, et al. Linkage and association of HLA class �� genes with vitiligo in a Dutch population. Br J Dermatol,2001, 145:90-94.
[12] Zhang XJ, Liu HS, Liang YH,et al. Association of HLA class �� alleles with vitiligo in Chinese Hans. J Dermatol Sci, 2004, 35:165.
[13] Le Poole IC, Sarangarajan R, Zhao Y, et al. "VIT1", a novel gene associated with vitiligo. Pigment Cell Res, 2001, 14:475-484.
[14] Jin SY, Park HH, Li GZ, et al. Association of angiotensin converting enzyme gene I/D polymorphism of vitiligo in Korean population. Pigment Cell Res, 2004, 17:84-86.
[15] Casp CB, She JX, McCormack WT. Genes of the LMP/TAP cluster are associated with the human autoimmune disease vitiligo. Genes Immun, 2003, 4:492-499.
[16] Casp CB, She JX, McCormack WT. Genetic association of the catalase gene (CAT) with vitiligo susceptibility. Pigment Cell Res,2002, 15:62-66.

��е��

1��ΰ,��.��[J]. ��Ƥ��Բ�ѧ��־, 2007,33(4): 222-

2��,��ѧ��.��ػ��о��ع�[J]. ��Ƥ��Բ�ѧ��־, 2007,33(4): 219-

3��,��ٺ�,֣־��.308 nm׼��Ӽ��ư��״[J]. ��Ƥ��Բ�ѧ��־, 2006,32(3): 150-

4��.խ��UVB311��UVB��ÿ��ư��[J]. ��Ƥ��Բ�ѧ��־, 2006,32(3): 161-

5��, ��.��[J]. ��Ƥ��Բ�ѧ��־, 2007,33(6): 355-357

6��Ҧ�ܲ�.��±��/��ư��[J]. ��Ƥ��Բ�ѧ��־, 2008,34(2): 77-77

7��,��.��Ƥ��зǺ��ϸ��չ[J]. ��Ƥ��Բ�ѧ��־, 2008,34(3): 178-180

8��,��.��ͯ��ٴ��ѧ�о�[J]. ��Ƥ��Բ�ѧ��־, 2008,34(4): 211-214

9��ѧ��,ξ��,��.��Ƥϸ��Һ��ֲ��ư��Ӱ��[J]. ��Ƥ��Բ�ѧ��־, 2008,34(4): 238-240

10��,ξ��,��.��縺ѹ��Ƥ��ֲ��Ӱ��[J]. ��Ƥ��Բ�ѧ��־, 2008,34(5): 305-307

11��zhuwu,��.��综�ߵ��ط��[J]. ��Ƥ��Բ�ѧ��־, 2008,34(5): 338-339